Balkrishna Acharya, Raj Preeti, Singh Pratima, Varshney Anurag
Patanjali Research Foundation Trust, Patanjali Yogpeeth, Haridwar, Uttarakhand, 249 405, India.
Department of Allied and Applied Sciences, University of Patanjali, Haridwar, Uttarakhand, 249 405, India.
Patient Prefer Adherence. 2021 Apr 29;15:899-909. doi: 10.2147/PPA.S302957. eCollection 2021.
The correlation among treatment satisfaction with demographic characteristics, health symptoms or psychological health, and quality of life with the prophylactic regime against COVID-19 is rather unexplored. This real-world exploratory study was conducted to determine patient-perspectives regarding their treatment satisfaction receiving Divya-Swasari-Coronil-Kit with correlative impacts on psychological health (PH) and Quality of life (QoL) based on four hypotheses each relating to PH, QoL, Demographic characteristics, and Treatment satisfaction.
This cross-sectional, web-based survey collected data on demographic characteristics and psychological health with DASS-21; QoL with 5-level 5-dimension EuroQol instrument; and treatment satisfaction using Treatment Satisfaction Questionnaire for Medication (TSQM) V9. Pearson correlation coefficient analysis was used to examine the relation between TSQM and PH and the demographic variables. Factor analysis was used for multi-collinearity tests, and multiple linear regression analysis was used to explore demographic variables and TSQM.
Out of 421 initial screenings, 367 patient-participants were included in the analysis. The mean age of included participants was 33.61 ± 9.47 years. Marital status and socio-economic class positively correlated with TSQM. Physical symptoms in patients are positively correlated with depression, anxiety, and stress; and in contrast, negatively with QoL. Global satisfaction with Divya-Swasari-Coronil-Kit medication negatively correlated with depression, anxiety, stress, effectiveness, convenience; whereas global satisfaction correlated positively with QoL.
Present study (SATISFACTION COVID) indicates that treatment satisfaction due to avaliablity and treatment of Divya-Swasari-Coronil-Kit has constructive and beneficial implications on psychological health, Quality of life and demographic factors. In addition, web-based patient-reported perspectives may well be a feasible way to provide better insights into treatment satisfaction, in relation to psychological health and Quality of life.
针对新冠肺炎预防方案的治疗满意度与人口统计学特征、健康症状或心理健康以及生活质量之间的相关性尚未得到充分研究。本项真实世界探索性研究旨在确定患者对Divya-Swasari-Coronil-Kit治疗满意度的看法,以及其对心理健康(PH)和生活质量(QoL)的相关影响,研究基于四个分别与PH、QoL、人口统计学特征和治疗满意度相关的假设展开。
本项横断面网络调查使用DASS-21收集人口统计学特征和心理健康数据;使用5级5维度欧洲生活质量量表收集生活质量数据;使用药物治疗满意度问卷(TSQM)V9收集治疗满意度数据。采用Pearson相关系数分析来检验TSQM与PH以及人口统计学变量之间的关系。使用因子分析进行多重共线性检验,并使用多元线性回归分析来探索人口统计学变量和TSQM。
在421名初始筛查者中,367名患者参与者被纳入分析。纳入参与者的平均年龄为33.61±9.47岁。婚姻状况和社会经济阶层与TSQM呈正相关。患者的身体症状与抑郁、焦虑和压力呈正相关;相反,与生活质量呈负相关。对Divya-Swasari-Coronil-Kit药物的总体满意度与抑郁、焦虑、压力、有效性、便利性呈负相关;而总体满意度与生活质量呈正相关。
本研究(SATISFACTION COVID)表明,Divya-Swasari-Coronil-Kit的可用性和治疗所带来的治疗满意度对心理健康、生活质量和人口统计学因素具有建设性和有益的影响。此外,基于网络的患者报告观点很可能是一种可行的方式,能够更好地洞察与心理健康和生活质量相关的治疗满意度。